Editorial Policy: The editors of the CancerConsultants develop and write all of the content information presented in the Patient Resource Center and retain sole and complete editorial control of the content. The posting of clinical trials on the Patient Resource Center is performed in exchange for a listing fee. All trials have been approved by the designated institutional review board for the institution conducting the trial prior to posting.

C. Dean Buckner, M.D., Scientific Editor
Dr. Buckner is a graduate of the University of Michigan Medical School and received his residency and post-graduate hematology and oncology training at the University of Washington and the National Cancer Institute. He helped pioneer autologous and allogeneic bone marrow and blood stem cell transplantation as a treatment for cancer with the team headed by E. Donnall Thomas, who received the 1990 Nobel Prize in Medicine for his work on transplantation biology. Dr. Buckner was a founding member of the Fred Hutchinson Cancer Research Center and Director of the Autologous Marrow Transplant Program. He has authored over 400 publications in the field of hematology and oncology, including many in the New England Journal of Medicine. In 1987, Dr. Buckner was awarded the Joseph Steiner award for achievements in bone marrow transplantation research. He is a founding board member of the Jose Carreras Foundation Against Leukemia and serves on several editorial boards. As a member of the National Cancer Institute grant review process, Dr. Buckner remains active in evaluating the quality of cancer research programs eligible to receive federal research funding. He is an advocate of promoting access to cancer care and clinical trials in the community setting.

Charles H. Weaver M.D., Managing Editor
Charles H. Weaver, M.D. is the founder of CancerConsultants.com. Dr. Weaver is a medical oncologist who trained at the University of Pennsylvania, National Institutes of Health, and Fred Hutchinson Cancer Research Center. He spent five years as Chief Medical Officer at Response Oncology Inc. In his role at Response Oncology, he developed and implemented the strategy for interfacing with biopharmaceutical companies, established the clinical research organization, created the site management organization and developed the managed care strategy. Dr. Weaver brings to CancerConsultants.com a wealth of knowledge and experience in the clinical and business practice of oncology. He has extensive contacts throughout the oncology pharmaceutical industry. He has a well-established record of collaborating in clinical research with the biopharmaceutical industry and has authored more than 100 publications.

Kevin A. Schulman M.D., Co-Editor
Kevin A. Schulman, M.D., is Professor of Medicine at the Duke University School of Medicine and Director of the Center for Clinical and Genetic Economics at Duke Clinical Research Institute. Dr. Schulman is an expert in technology assessment related to new pharmaceutical products and new clinical therapies, and is the principal outcomes investigator for many major multinational clinical trials, including several related to supportive care treatments in oncology. Dr. Schulman is the author of over 100 peer-reviewed articles, book chapters, editorials and reviews, and over 100 abstracts. Dr. Schulman is also a member of the editorial board of seven major medical journals.

Disclosure:
The Patient Resource Center web site and service is free to patients and their families. To ensure easy reading, free of distractions, advertising is not sold on the Patient Resource Center.

Manufacturers of biopharmaceutical products, however, may sponsor content development and have their product hyperlinked within the Patient Resource Center content sections so that readers may directly access additional product information from the manufacturers when desired.